Director makes $2 million buy.
On Thursday, August 8th, Mellody Hobson, a director at JPMorgan Chase (JPM), bought 18,200 shares, increasing her stake to just over 101,300 shares. The total cost of this latest buy came in at just over $2 million.
Hobson has been a repeat buyer of shares this year, buying 19,700 shares back in April. Many insiders at the big bank have been sellers of shares this year, although at higher prices than where shares currently trade.
- This Company’s Share Price has Increased 1650% Since 2016.
Traditional pharmacies can be a headache. That’s why NowRx has rebuilt the retail pharmacy experience to be more convenient, personalized, and hassle-free for customers – and their potential is growing quickly.
This year, the company is on pace to surpass $22M in revenue and with their newest telehealth product growing 73% MoM, the time to invest has never been better!
Did we mention that retail pharmacy is a $480B industry? You’re going to want a piece of that.
Check out NowRx for yourself and explore the investment opportunity today.
JPMorgan Chase is a global financial powerhouse, with traditional banking, commercial and investment banking, wealth management, and other services for customers large and small. The company was founded in 1799 and employs nearly 250,000 worldwide.
Action to take: Banks and other financials have been hard-hit by the recent trade-war fears. However, falling interest rates lower the cost of capital to banks, and more origination activity could occur for mortgages and business loans as rates decline.
The bank looks attractively valued at 11 times earnings, and with its high profit margin. The underperformance in shares this past year has also led to a 3.3 percent dividend yield, on the high side for large banks. Shares look attractive as a long-term buy under $110 per share, and traders should look at buying call options on the bank when financials have a brutal day in the market.